Indeed, Richards et al. [165] found that TSPO binding (recall that this is a marker of microglial activation) is highest in patients with depression who are not on antidepressant medication, whereas medicated participants show comparable TSPO binding to undepressed controls. This evidence concerns the gene TSPO and depressive disorder.